<VariationArchive VariationID="667417" VariationName="NM_170606.3(KMT2C):c.3462del (p.Leu1155_Val1156insTer)" VariationType="Deletion" Accession="VCV000667417" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2019-08-26" MostRecentSubmission="2019-08-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="654481" VariationID="667417">
      <GeneList>
        <Gene Symbol="KMT2C" FullName="lysine methyltransferase 2C" GeneID="58508" HGNC_ID="HGNC:13726" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="152134925" stop="152436003" display_start="152134925" display_stop="152436003" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="151832009" stop="152133089" display_start="151832009" display_stop="152133089" Strand="-" />
          </Location>
          <OMIM>606833</OMIM>
          <Haploinsufficiency last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2C">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-01-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2C">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_170606.3(KMT2C):c.3462del (p.Leu1155_Val1156insTer)</Name>
      <CanonicalSPDI>NC_000007.14:152222037:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q36.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="152222038" stop="152222038" display_start="152222038" display_stop="152222038" variantLength="1" positionVCF="152222037" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="151919123" stop="151919123" display_start="151919123" display_stop="151919123" variantLength="1" positionVCF="151919122" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.151919123del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.151919123del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.152222038del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.152222038del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033948.1" sequenceAccession="NG_033948" sequenceVersion="1" change="g.218968del">
            <Expression>NG_033948.1:g.218968del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170606.3" sequenceAccession="NM_170606" sequenceVersion="3" change="c.3462del" MANESelect="true">
            <Expression>NM_170606.3:c.3462del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_733751.2" sequenceAccession="NP_733751" sequenceVersion="2" change="p.Leu1155_Val1156insTer">
            <Expression>NP_733751.2:p.Leu1155_Val1156insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170606.3" sequenceAccession="NM_170606" sequenceVersion="3" change="c.3462delA" MANESelect="true">
            <Expression>NM_170606.3:c.3462delA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1588343792" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_170606.3(KMT2C):c.3462del (p.Leu1155_Val1156insTer) AND Kleefstra syndrome due to a point mutation" Accession="RCV000826194" Version="4">
        <ClassifiedConditionList TraitSetID="48391">
          <ClassifiedCondition DB="MedGen" ID="C5680724">Kleefstra syndrome due to a point mutation</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-10-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-26" MostRecentSubmission="2019-08-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="48391" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="42442" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome due to a point mutation</ElementValue>
                <XRef ID="MONDO:0016865" DB="MONDO" />
                <XRef ID="90830420" DB="NCBI for submitter" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17253" />
                <XRef ID="17253" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="261652" DB="Orphanet" />
              <XRef ID="C5680724" DB="MedGen" />
              <XRef ID="MONDO:0016865" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1895538" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="90830420|Orphanet:ORPHA261652" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000967744" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Val1156X variant in KMT2C has not been previously reported in diseased ind ividuals, nor in large population studies. However, this variant was confirmed t o be de novo in an individual with mild intellectual disability, autism, seizure s, sensorineural hearing loss, gastroparesis, and supraventricular tachycardia b y the Broad Institute Rare Genomes Project. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at positio n 1156 and leads to a premature termination codon at this position. This alterat ion is then predicted to lead to absent protein. Heterozygous loss of function o f the KMT2C gene is an established disease mechanism in individuals with Kleefst ra 2 syndrome. In summary, this variant meets criteria to be classified as patho genic for Kleefstra 2 syndrome in an autosomal dominant manner based upon de nov o occurrence, its absence from the general population, and its predicted impact on the protein. ACMG/AMP Criteria applied: PVS1, PS2, PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2C" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_170606.2:EXON 22</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_170606.2:c.3462delA</Name>
            <Name>p.Val1156X</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.151919123delT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Kleefstra syndrome due to a point mutation</ElementValue>
            </Name>
            <XRef DB="Orphanet" ID="ORPHA261652" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1895538" TraitType="Disease" MappingType="Name" MappingValue="Kleefstra syndrome due to a point mutation" MappingRef="Preferred">
        <MedGen CUI="C5680724" Name="Kleefstra syndrome due to a point mutation" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

